Weekly Recap | Twist Bioscience +3.19%, consensus target below spotWeekly Review·Oct 3, 2026 at 08:40 AMTWST-18.55%
Weekly Recap | Alnylam Pharma -14.16%, one-way sellingWeekly Review·Oct 3, 2026 at 08:28 AMALNY+1.84%
Weekly Recap | RXRX.US +10.16%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:37 AMRXRX-3.14%
Weekly Recap | Roche -4.04%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:34 AMRHHBY+0.08%
Weekly Recap | PURR.US -7.47%, consensus target above spotWeekly Review·Oct 3, 2026 at 07:30 AMPURR-3.25%
Weekly Recap | Kodiak Sciences +191.96%, Zenkuda hits phase 3 goalWeekly Review·Oct 3, 2026 at 07:06 AMKOD-1.57%
Weekly Recap | BioNTech SE this week, CEO trims shares repeatedlyWeekly Review·Oct 3, 2026 at 06:25 AMBNTX-1.96%
Weekly Recap | ABSI.US +13.66%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 06:09 AMABSI-10.93%
Weekly Recap | SPDR S&P Biotech -0.39%, busy week of biotech headlinesWeekly Review·Oct 3, 2026 at 05:05 AMXBI-3.39%
Weekly Recap | ARKG.US +1.2%, closing in on record highsWeekly Review·Oct 3, 2026 at 04:10 AMARKG-8.84%
